Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boldt, J.
Right arrow Articles by Hempelmann, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boldt, J.
Right arrow Articles by Hempelmann, G.
(Chest. 1995;107:787-792.)
© 1995 American College of Chest Physicians

Do Plasma Levels of Circulating Soluble Adhesion Molecules Differ Between Surviving and Nonsurviving Critically Ill Patients?

Joachim Boldt MD, FCCP1; Matthias Wollbrück MD1; Detleft Kuhn MD1; L. Christoph Linke 1; and Gunter Hempelmann MD1

1 From the Department of Anesthesiology and Intensive Care Medicine, Justus-Liebig-University Giessen, Giessen, Germany

Adhesion molecules appear to play a central role in tissue damage secondary to inflammatory response. Besides various neutrophil- and endothelial-bound adhesion molecules, soluble forms of endothelial-derived adhesion molecules have been detected in the circulating blood in recent years. They seem to be good markers of endothelial damage, but their importance in the critically ill has not been definitely elucidated yet. Plasma levels of circulating (soluble) adhesion molecules (endothelial leucocyte adhesion molecules [sELAM-1], vascular cell adhesion molecule 1 [sVCAM-1], intercellular adhesion molecule 1 [sICAM-l]) were serially measured from arterial blood samples using en zyme-linked immunosorbent assays (ELISA) in 50 consecutive patients suffering from severe trauma (injury severity score [ISS] >25 points) or postoperative complications. Measurements were carried out on the day of admission on the intensive care unit (ICU) ("baseline" value) and during the next 5 days. Survival was defined as survival throughout the study period. The survivor group (n=30) consisted of more patients who had sustained trauma (53%), whereas in the nonsurvivors (n=20) more patients with postoperative complications were found (65%). On admission to ICU, septic shock was more often seen in the nonsurvivors (30%) than in the survivors (13%) and the nonsurvivors showed a slightly higher APACHE II score at baseline. At baseline, plasma levels of all three adhesion molecules were elevated beyond normal range in both groups. The sICAM-1 and sELAM-1 plasma concentrations were significantly higher in the nonsurvivors than in the survivors already at baseline. The sELAM-1 and sICAM-1 values significantly decreased in the survivors without reaching normal values. At the end of the investigation period, sVCAM-1 plasma level was within normal range in the survivors. In the nonsurvivors, all three adhesion molecules increased significantly throughout the study period (sELAM-1, from 115±31 to 158±23 ng/mL; sLCAM-1, from 830±210 to 1,536±199 ng/mL; sVCAM-1, from 861±168 to 1,249±151 ng/mL). None of the other hemodynamic or laboratory variables could be correlated with the time course of adhesion molecules, except for PaO2/PaO2 ratio, which was negatively correlated with plasma levels of soluble adhesion molecules in the nonsurvivors (analysis of covariance). It is concluded that plasma levels of soluble adhesion molecules were markedly higher in nonsurviving than in surviving critically ill patients. They may possibly serve as markers of the extent of inflammatory response, of the endothelial damage in patients at risk of multiple-organ failure or both. Their role in critical illness, however, is not definitely clarified. Thus, it has to be elucidated whether preventing an increase in soluble adhesion molecules is of benefit for the patient's organ function or even outcome.

Key Words: critically ill • sepsis • endothelium • inflammatory response • neutrophils • nonsurvivors • outcome • soluble adhesion molecules • soluble endothelial leukocyte adhesion molecules (sELAM-1) • soluble intercellular adhesion molecule 1 (sICAM-1) • soluble vascular cell adhesion molecule 1 (sVCAM-1) • survivors • tissue damage

Submitted on May 2, 1994
Accepted on July 27, 2007




This article has been cited by other articles:


Home page
Arch SurgHome page
A. E. Baue
Mediators or Markers of Injury, Inflammation, and Infection (Harbingers of Doom or Predictors of Disaster) and Biologic Puzzles or Ambiguities
Arch Surg, January 1, 2007; 142(1): 89 - 93.
[Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
R. M. Levy, J. M. Prince, R. Yang, K. P. Mollen, H. Liao, G. A. Watson, M. P. Fink, Y. Vodovotz, and T. R. Billiar
Systemic inflammation and remote organ damage following bilateral femur fracture requires Toll-like receptor 4
Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2006; 291(4): R970 - R976.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
S. KAYAL, J.-P. JAIS, N. AGUINI, J. CHAUDIERE, and J. LABROUSSE
Elevated Circulating E-Selectin, Intercellular Adhesion Molecule 1, and von Willebrand Factor in Patients with Severe Infection
Am. J. Respir. Crit. Care Med., March 1, 1998; 157(3): 776 - 784.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
C. J. CUMMINGS, C. N. SESSLER, L. D. BEALL, B. J. FISHER, A. M. BEST, and A. A. FOWLER III
Soluble E-Selectin Levels in Sepsis and Critical Illness . Correlation with Infection and Hemodynamic Dysfunction
Am. J. Respir. Crit. Care Med., July 1, 1997; 156(2): 431 - 437.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1995 by the American College of Chest Physicians.